AGENUS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.69 USD | +40.84% |
|
+120.15% | -29.40% |
| Apr. 12 | Sector Update: Health Care Stocks Slipping Late Afternoon | MT |
| Apr. 12 | Sector Update: Health Care | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 559.1 | 604.7 | 827 | 731.5 | 315.8 | 245.4 | - | - |
| Enterprise Value (EV) 1 | 559.1 | 604.7 | 827 | 731.5 | 315.8 | 245.4 | 245.4 | 245.4 |
| P/E ratio | -5.09 x | -3.03 x | -29.3 x | -3.08 x | -1.2 x | -1.51 x | -0.91 x | -1.27 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 3.73 x | 6.86 x | 2.8 x | 7.46 x | 2.02 x | 0.86 x | 1.23 x | 0.82 x |
| EV / Revenue | 3.73 x | 6.86 x | 2.8 x | 7.46 x | 2.02 x | 0.86 x | 1.23 x | 0.82 x |
| EV / EBITDA | - | - | - | -4,745,874 x | - | - | - | - |
| EV / FCF | -24 x | -4.24 x | -34.9 x | -3.2 x | -1.35 x | 1.16 x | -2.05 x | -3.01 x |
| FCF Yield | -4.17% | -23.6% | -2.86% | -31.2% | -74.1% | 86.2% | -48.8% | -33.2% |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 6,868 | 9,507 | 12,842 | 15,241 | 19,075 | 20,995 | - | - |
| Reference price 2 | 81.40 | 63.60 | 64.40 | 48.00 | 16.56 | 11.69 | 11.69 | 11.69 |
| Announcement Date | 3/12/20 | 3/15/21 | 3/1/22 | 3/14/23 | 3/14/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 150 | 88.17 | 295.7 | 98.02 | 156.3 | 284.1 | 199.2 | 298.2 |
| EBITDA | - | - | - | -154.1 | - | - | - | - |
| EBIT 1 | -70.14 | -114.9 | 25.75 | -179.4 | -159.5 | -67.28 | -177.2 | -113.4 |
| Operating Margin | -46.74% | -130.3% | 8.71% | -183.04% | -102.07% | -23.68% | -88.95% | -38.03% |
| Earnings before Tax (EBT) 1 | -111.6 | -182.9 | -28.72 | -230.7 | -257.4 | -112.2 | -227.2 | -175 |
| Net income 1 | -111.6 | -182.9 | -24.14 | -230.7 | -257.4 | -154.3 | -268.9 | -206.4 |
| Net margin | -74.35% | -207.43% | -8.16% | -235.31% | -164.69% | -54.32% | -134.97% | -69.23% |
| EPS 2 | -16.00 | -21.00 | -2.200 | -15.60 | -13.80 | -7.754 | -12.91 | -9.206 |
| Free Cash Flow 1 | -23.34 | -142.6 | -23.67 | -228.4 | -234.2 | 211.6 | -119.7 | -81.6 |
| FCF margin | -15.55% | -161.69% | -8.01% | -233.04% | -149.8% | 74.48% | -60.08% | -27.37% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/12/20 | 3/15/21 | 3/1/22 | 3/14/23 | 3/14/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 253 | 20.26 | 25.94 | 20.93 | 22.77 | 28.39 | 22.9 | 25.3 | 24.31 | 83.8 | 57.17 | 72.25 | 97.36 | 57.36 | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 187.5 | -54.03 | -35.46 | -44.56 | -41.64 | -57.76 | -54.34 | -54.67 | -46.34 | -4.201 | -27.48 | -14.33 | 8.372 | -33.92 | - |
| Operating Margin | 74.14% | -266.66% | -136.7% | -212.96% | -182.88% | -203.47% | -237.28% | -216.11% | -190.59% | -5.01% | -48.07% | -19.83% | 8.6% | -59.13% | - |
| Earnings before Tax (EBT) 1 | 177.3 | -67.61 | -50.6 | -49.24 | -56.72 | -74.1 | -70.89 | -73.43 | -64.53 | -48.58 | -42.49 | -25.65 | 3.563 | -47.65 | - |
| Net income 1 | 177.3 | -65.56 | -48.38 | -49.24 | -54.28 | -74.1 | -70.89 | -73.43 | -64.53 | -48.58 | -53.52 | -36.08 | -14.26 | -55.67 | - |
| Net margin | 70.08% | -323.6% | -186.49% | -235.28% | -238.34% | -261.05% | -309.55% | -290.28% | -265.41% | -57.97% | -93.61% | -49.94% | -14.65% | -97.06% | - |
| EPS 2 | 14.40 | -5.800 | -3.800 | -3.400 | -3.800 | -4.800 | -4.400 | -4.000 | -3.200 | -2.600 | -2.830 | -1.840 | -0.5120 | -2.782 | -5.110 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/9/21 | 3/1/22 | 5/10/22 | 8/9/22 | 11/8/22 | 3/14/23 | 5/9/23 | 8/8/23 | 11/7/23 | 3/14/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -23.3 | -143 | -23.7 | -228 | -234 | 212 | -120 | -81.6 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 4.66 | 3.47 | 33.8 | 53.1 | 9.95 | 3.2 | 8.4 | 24.7 |
| Capex / Sales | 3.1% | 3.93% | 11.44% | 54.13% | 6.37% | 1.13% | 4.22% | 8.28% |
| Announcement Date | 3/12/20 | 3/15/21 | 3/1/22 | 3/14/23 | 3/14/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
11.69
USD
Average target price
88.75
USD
Spread / Average Target
+659.20%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.40% | 245M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- AGEN Stock
- Financials Agenus Inc.
